Wednesday, January 1, 2020 Daily Archives

Korean CDMOs set for Government-backed biopharma boom

by

South Korean CDMOs are poised for significant growth after the Government said contractors are key to its efforts to encourage drug R&D and manufacturing in the country. In May South Korean President Jae-in Moon announced this summer that the country will invest more than KRW 2 trillion ($1.7B) in the biotechnology and biopharmaceutical industry. Moon said, “We will do our best to create an ecology of innovation tailored to all stages of growth from technological development and approval and licensing…

January 1, 2020

Dendreon extends lease on Atlanta Provenge plant

by

Dendreon has extended the lease for the facility in Union City near Atlanta where it makes its prostate cancer cell therapy, Provenge (sipuleucel-T). The Chinese-owned cell therapy firm first leased the 155,000 square-foot facility in 2009, shortly before Provenge was approved by the US Food and Drug Administration (FDA). The extension covers use of the Union City site through to 2029. Christina Yi, chief operations officer at Dendreon said, “Over the past 10 years, we have grown locally, building key…

January 1, 2020